| Authors: |
Aboshi M; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Kawakami D; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Kono K; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Nishiyama A; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan., Nogimori T; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan., Sunada Y; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Matsuda K; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Sekida T; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Suga S; National Hospital Organization, Mie National Hospital, Tsu, Mie 514-0125, Japan., Smith JF; VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA., Sato N; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan., Yamamoto T; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health, and Nutrition, Osaka 567-0085, Japan.; Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka 565-0871, Japan.; Department of Virology and Immunology, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan., Akahata W; VLP Therapeutics Japan, Inc., 1-2-9 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan. |
